Beam Therapeutics (BEAM) FCF Margin (2019 - 2026)
Beam Therapeutics (BEAM) reported FCF Margin of 411.95% for Q1 2026, up 99821.0% year-over-year from N/an in Q1 2025, and down 477.24% on a QoQ basis from 71.37% in Q4 2025.
Beam Therapeutics (BEAM) has 8 years of FCF Margin data on file, last reported at 411.95% in Q1 2026.
- Quarterly FCF Margin rose 99821.0% year-over-year to 411.95% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 226.68% (up 32904.0% YoY) and the FY2025 annual result came in at 247.86%, up 30014.0% from the prior year.
- FCF Margin slipped to 411.95% in Q1 2026 per BEAM's latest filing, from 71.37% in the prior quarter.
- Across five years, FCF Margin topped out at 2505.11% in Q1 2022 and bottomed at 1410.16% in Q1 2025.
- The 5-year median for FCF Margin is 497.73% (2023), against an average of 408.15%.
- The widest annual swing landed in 2022, when FCF Margin soared 83677178 bps; it then slumped 300284 bps in 2023.
- Tracing BEAM's FCF Margin over 5 years: stood at 561.38% in 2022, then jumped by 107 bps to 41.58% in 2023, then plunged by 670 bps to 236.88% in 2024, then soared by 70 bps to 71.37% in 2025, then tumbled by 477 bps to 411.95% in 2026.
- Per Business Quant, the three latest BEAM FCF Margin figures stand at 411.95% (Q1 2026), 71.37% (Q4 2025), and 808.46% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4.17% |
| 10 | Beam Therapeutics | 3.40 Bn | 3.40 Bn | - | -411.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -411.95% |
| Dec 31, 2025 | -71.37% |
| Sep 30, 2025 | -808.46% |
| Jun 30, 2025 | -959.08% |
| Mar 31, 2025 | -1,410.16% |
| Dec 31, 2024 | -236.88% |
| Sep 30, 2024 | -655.83% |
| Jun 30, 2024 | -706.52% |
| Mar 31, 2024 | -1,350.94% |
| Dec 31, 2023 | 41.58% |
| Sep 30, 2023 | -568.44% |
| Jun 30, 2023 | -478.17% |
| Mar 31, 2023 | -497.73% |
| Dec 31, 2022 | -561.38% |
| Sep 30, 2022 | -324.39% |
| Jun 30, 2022 | -443.91% |
| Mar 31, 2022 | 2,505.11% |
| Dec 31, 2021 | 50.93% |
| Sep 30, 2021 | -3,408.26% |
| Jun 30, 2021 | -424,650.00% |
| Mar 31, 2021 | -834,266.67% |
| Dec 31, 2020 | -442,600.00% |
| Sep 30, 2020 | -387,916.67% |
| Jun 30, 2020 | -375,866.67% |
| Mar 31, 2020 | -473,750.00% |
| Dec 31, 2019 | -165,116.67% |
| Sep 30, 2019 | -441,100.00% |
| Jun 30, 2019 | -177,750.00% |